Table 1.
Participant characteristics (n = 90).
| Characteristics | GroupQuit (n = 14) | PhoneQuit (n = 39) | SmartQuit (n = 37) | Total (n = 90) |
|---|---|---|---|---|
| Age (mean, SD) | 57.3 (6.9) | 60.6 (1.2) | 55.5 (13.1) | 58.0 (10.2) |
| Gender | ||||
| Male | 4 (28.6%) | 20 (51.3%) | 16 (43.2%) | 40 (44.4%) |
| Female | 10 (71.4%) | 19 (48.7%) | 21 (56.8%) | 50 (55.5%) |
| Race2 | ||||
| White | 9 (64.3%) | 30 (76.9%) | 29 (78.4%) | 68 (75.6%) |
| Black/African American | 4 (28.6%) | 8 (20.5%) | 5 (13.5%) | 17 (18.9%) |
| Other | 3 (17.0%) | 2 (5.5%) | 4 (10.8%) | 9 (10.0%) |
| Ethnicity | ||||
| Hispanic | 1 (7.1%) | 0 (0.0%) | 1 (2.7%) | 2 (2.2%) |
| Non-Hispanic | 13 (92.9%) | 39 (100.0%) | 36 (97.3%) | 88 (97.8%) |
| Marital status | ||||
| Married or cohabitating | 6 (42.9%) | 24 (61.5%) | 15 (40.5%) | 45 (50.0%) |
| Not married or cohabitating | 8 (57.1%) | 15 (39.5%) | 22 (59.4%) | 45 (50.0%) |
| Rurality a | ||||
| Urban | 8 (57.1%) | 28 (71.8%) | 26 (70.3%) | 62 (68.9%) |
| Rural | 6 (42.9%) | 11 (28.2%) | 11 (29.7%) | 28 (31.1%) |
| Cigarette smoking frequency | ||||
| Every day | 13 (92.9%) | 30 (76.9%) | 34 (91.9%) | 77 (85.6%) |
| Some days | 0 (0.0%) | 7 (17.9%) | 3 (8.1%) | 10 (11.1%) |
| E-cigarette use frequency | ||||
| Every day | 1 (7.1%) | 1 (2.6%) | 4 (10.8%) | 6 (6.7%) |
| Some days | 1 (7.1%) | 10 (25.6%) | 6 (16.2%) | 17 (18.9%) |
| Not at all | 11 (78.6%) | 27 (69.2%) | 27 (73.0%) | 65 (72.2%) |
| Cigarettes/day (mean, SD) | 20.1 (15.1) | 12.3 (8.5) | 13.8 (12.1) | 14.2 (11.5) |
| Age of smoking initiation (mean, SD) | 21.0 (8.1) | 18.9 (6.5) | 16.2 (6.4) | 17.0 (8.0) |
| PEI composite score (1–10) | 6.9 (2.9) | 7.2 (2.9) | 7.7 (2.6) | 7.4 (2.7) |
| Cancer diagnosis | ||||
| Past week | 1 (7.1%) | 2 (5.1%) | 2 (5.4%) | 5 (5.6%) |
| Past month | 0 (0.0%) | 4 (10.3%) | 5 (13.5%) | 9 (10.0%) |
| Past 1–3 months | 3 (21.4%) | 7 (17.9%) | 4 (10.8%) | 14 (15.6%) |
| Past 4–6 months | 3 (21.4%) | 7 (17.9%) | 7 (18.9%) | 17 (18.9%) |
| Past 7–12 months | 2 (14.3%) | 2 (5.1%) | 3 (8.1%) | 7 (7.8%) |
| Over 12 months | 5 (35.7%) | 17 (43.6%) | 16 (43.2%) | 38 (42.2%) |
| Cancer site b | ||||
| Lung | 4 (28.6%) | 11 (28.2%) | 11 (29.7%) | 26 (28.9%) |
| Head and neck | 5 (35.7%) | 8 (20.5%) | 20 (54.1%) | 33 (36.7%) |
| Breast | 0 (0.0%) | 6 (15.4%) | 7 (18.9%) | 13 (14.4%) |
| Gastrointestinal | 5 (35.7%) | 11 (28.2%) | 5 (13.5%) | 21 (23.3%) |
| Thyroid | 0 (0.0%) | 2 (5.1%) | 0 (0.0%) | 2 (2.2%) |
| Genitourinary | 2 (14.3%) | 7 (17.9%) | 3 (8.1%) | 12 (13.3%) |
| Gynecologic | 2 (14.3%) | 1 (2.6%) | 2 (5.4%) | 5 (5.5%) |
| Bone | 2 (14.3%) | 4 (10.3%) | 3 (8.1%) | 9 (10.0%) |
| Brain | 2 (14.3%) | 4 (10.3%) | 1 (2.7%) | 7 (7.8%) |
| Hematologic/Blood | 4 (28.6%) | 3 (7.7%) | 4 (10.8%) | 11 (12.2%) |
| Other | 1 (7.1%) | 3 (7.7%) | 1 (2.7%) | 5 (5.6%) |
a Could choose more than response; b RUCA 1–3 = urban, RUCA 4–10 = rural.